Showing posts with label Bladder Cancer. Show all posts
Showing posts with label Bladder Cancer. Show all posts

Thursday, August 4, 2011

Emedinews: Makesure: A chronic smoker developed cancer of lung


Situation: A chronic smoker developed cancer of lung
Reaction: Oh my God!! Why was he not screened earlier for cancer of lung?
Lesson: Make sure that all chronic smokers are given an option for lung cancer screening with low dose spiral CT.



Sunday, July 31, 2011

Avoid cardiac catheter based imaging procedures if not a must

One should not opt for imaging studies unless it is a must; they are not safe and can cause cancers in long run.
A UK analysis published in the Journal Lancet in 2004 had shown that fluoroscopic X Ray radiation exposure during catheter-based coronary angiography can cause up to 280 cases of cancer per million examinations performed.
The mean duration of fluoroscopy in electro physiologic cardiac interventional procedures ranges from 15 to 67 minutes. The radiation dose from one hour of fluoroscopy during electro physiologic ablation procedures can result in 0.7 to 1.4 excess fatal malignancies per 1000 women and 1.0 to 2.6 per 1000 men as per two studies published in American Journal of Cardiology (1998) and Circulation (2004)
 At doses used in diagnostic and interventional procedures, ionizing radiation releases free radicals that may cause DNA damage. This radiation-induced cancers may develop decades after exposure, and include myeloma, blood cancers, lung cancer, thyroid cancer, breast cancer, bone cancer, and skin cancer.
Effective dose of radiation is measured in sieverts (Sv) or millisieverts (mSv). A whole body radiation dose of 1 Sv is associated with a 4 to 5 percent increased relative risk of fatal cancer. (1 Sv = 1000 mSv).
Mild exposure is called when the exposure is < 3 mSv, Moderate >3 to 20 mSv, High 20 to 50 mSv and very high exposure means >50 mSv.
The effective dose related to any radiologic procedure can be considered in the context of the annual effective dose to individuals from natural background radiation sources, including radon, cosmic rays, terrestrial, and internal sources. This background effective dose, approximately 3 mSv, does not pose a significant risk of future cancer to individuals.
A typical X ray procedure results in a total effective dose of 8.3 mSv per hour of fluoroscopy.  The mean cardiac fluoroscopy time in managing paroxysmal atrial fibrillation is 57 minutes, atrial flutter is 20 minutes, ablation is 22 minutes and Pulmonary Vein isolation is 39 minutes.
Multiple medical tests involving radiation exposure lead to high cumulative doses of radiation. In one study in 20 year period a heart patient may end up with 15 procedures involving radiation exposure. Of these four may be high dose procedures (≥3 mSv). The cumulative estimated effective dose from all medical sources exceeds 100 mSv in 31.4 percent of patients.
Use of CT may account for 1.5 to 2 percent of all future cancers in the United States.
The 2006 Biological Effects of Ionizing Radiation VII lifetime attributable cancer risk model predicts that 1 in 1000 persons exposed to 10 mSv (single diagnostic CT scan of the neck, chest, abdomen, or pelvis) will develop cancer due to that single exposure.
The lifetime attributable cancer mortality risk attributable to a single radiation exposure in a one year-old child is 1 in 550 following an abdominal CT and 1 in 1500 following a brain CT.
It has been estimated that 29,000 future cancers could be attributed to CT scans performed in the US in 2007 alone.
1 in 500 women and 1 in 660 men will develop cancer from their abdominal CT scan if the procedure is performed at the age of 20.
A 45 year-old adult undergoing one single full-body CT procedure would accrue an additional lifetime attributable cancer mortality risk of 0.08 percent from a single scan.
The lifetime attributable cancer mortality risk is 1.9 percent lifetime for thirty years of annual scans.
All patients should be given a general idea about the magnitude of the proposed radiation dose. The exposure should be compared with an estimated effective dose to a single chest x-ray (0.02 mSv), a transcontinental airplane flight (0.02 mSv), or annual individual radiation dose from the natural background (3.0 mSv).
The dose from a single abdominal CT scan is comparable to the collective dose of 400 chest x-rays or natural background radiation for three years.  

Friday, July 22, 2011

Emedinews Makesure: A chronic smoker developed cancer of lung.


Situation: A chronic smoker developed cancer of lung. 
Reaction: Oh my God! Why was he not screened for the cancer?
Lesson: Make sure all chronic smokers are given an option for lung cancer screening with low dose spiral CT.

Dr KK Answers: Can Soy Supplements lower Blood Pressure?

According to a study published online in Circulation, soy and milk protein supplements are associated with lower blood pressure more than refined carbohydrate supplements in patients with mild hypertension. In the study
1.       Refined carbohydrates have no measurable effect on blood pressure
2.       Soy and milk protein supplements lower systolic blood pressure by about two points
3.       HDL cholesterol level was significantly higher with soy protein than with the other two supplements
4.       While the reduction in blood pressure was small, the benefits could translate to reduced numbers of strokes and other cardiovascular problems in the population as a whole.
5.       Replacing some refined carbohydrates -- such as white bread and white rice -- in the diet with soy or milk protein 'might be an important component of nutrition intervention strategies for the prevention and treatment of hypertension.

Dr KK Answers: Are taller women at greater risk of cancers?

Tall women are at greater overall risk for cancer than their short counterparts. As per a large U.K. prospective study by Jane Green, DPhil, of the University of Oxford published in Lancet Oncology for every four-inch increase in height over 5 feet, women had a 16% greater risk of developing cancer. The highest relative risks per four-inch height increase were for malignant melanoma, kidney cancer, and leukemia.

Tuesday, June 21, 2011

Don’t discard diabetic drug Pioglitazone even after the FDA’s Safety Announcement

The U.S. Food and Drug Administration has announced that the use of the popular diabetic drug pioglitazone for more than one year may be associated with an increased risk of bladder cancer.
According to the FDA’s Safety Announcement, information about this risk will be added to the Warnings and Precautions section of the label for pioglitazone-containing medicines.
However the Endocrine Society, American Association of Clinical Endocrinologists and American Diabetes Association inspite of the FDA announcement have urged diabetes patients not to panic and stop the drug without their doctor’s advice.  Stopping diabetic drug can result in higher levels of blood glucose that may cause serious short term health problems and could increase the risk of diabetes-related complications in the long term.
As per the advice all diabetics should adhere to the following guidance provided by the FDA:
1.       All diabetics should be told that there may be an increased chance of having bladder cancer when taking pioglitazone
2.        One should not take pioglitazone if receiving treatment for bladder cancer;
3.        One should consult right away if one has any of the symptoms of bladder cancer including blood or red color in urine; urgent need to urinate or pain while urinating; pain in back or lower abdomen;
According to the FDA Safety Announcement, the five-year interim analysis of an ongoing ten-year study showed that although there was no overall increased risk of bladder cancer with pioglitazone use, an increased risk of bladder cancer was noted among patients who had been on pioglitazone the longest and had been on higher doses over time.
Large number of diabetics are on pioglitazone which reduces insulin resistance and is useful in metabolic syndrome. The drug is already in criticism for gaining weight and possible heart failure.
About the author: Padmashri & Dr. B.C. Roy National Awardee, Dr. KK Aggarwal is a Senior Consultant, Physician, Cardiologist at Delhi based Moolchand Medcity; President Heart Care Foundation of India; Chairman Ethical Committee Delhi Medical Council and has served as the Research and Academic Wing Heads of National Indian Medical Association.